This is a preprint.
Versatile wastewater monitoring of pathogens and antimicrobial resistance enabled by metatranscriptomics and long-read metagenomics
- PMID: 40964040
- PMCID: PMC12440100
- DOI: 10.21203/rs.3.rs-7492978/v1
Versatile wastewater monitoring of pathogens and antimicrobial resistance enabled by metatranscriptomics and long-read metagenomics
Abstract
Widespread interest in the development of population-wide pathogen and antimicrobial resistance (AMR) monitoring has revealed wastewater's microbial footprint as a marker of public health. Near-source wastewater remains a difficult sample type for microbiome analyses but represents a closer link to human health than the downstream products of its treatment. Few studies integrate methods for non-targeted monitoring applications, and critically, current methods cannot connect AMR genes to species, nor resolve full genomes. We address these challenges by developing a pipeline that enables untargeted metagenomics, metatranscriptomics, and novel long-read metagenomics (LRG). We achieve untargeted pathogen detection, limited by highly abundant resident species, while retaining microbial information with near-source sampling. Furthermore, LRG identifies antibiotic resistance gene-containing microbes and enables assembly of culture-independent genomes with previously unreported AMR genes. We establish an integrated approach to broadly monitor pathogens in wastewater, while demonstrating the importance of LRG to illuminate microbial AMR at the species level.
Conflict of interest statement
R.K. is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant for DayTwo, and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. K.G.A. has received consulting fees for work on SARS-CoV-2 and the COVID-19 pandemic. He is on the SAB of Invivyd Inc. A.B. is a founder of Guilden Corporation and is an equity owner. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. M.O.D. has equity in GenCirq. D.M. is a consultant for BiomeSense, Inc., has equity and receives income. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
Figures
References
-
- Choi P. M. et al. Wastewater-based epidemiology biomarkers: Past, present and future. TrAC Trends Anal. Chem. 105, 453–469 (2018).
-
- Singer A. C. et al. A world of wastewater-based epidemiology. Nat. Water 1, 408–415 (2023).
-
- Ko K. K. K., Chng K. R. & Nagarajan N. Metagenomics-enabled microbial surveillance. Nat. Microbiol. 7, 486–496 (2022). - PubMed
-
- Diamond M. B. et al. Wastewater surveillance of pathogens can inform public health responses. Nat. Med. 28, 1992–1995 (2022). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
